Onward Medical NV ONWD

AMS: ONWD | ISIN: NL0015000HT4 17/09/2025

5,150 EUR (-0,58%)

(-0,58%) 17/09/2025

Grafiek Onward Medical NV

Grafiek Onward Medical NV

1 dag1d -0,58%
1 week1w 0,39%
1 maand1m 24,40%
3 maanden3m 16,52%
6 maanden6m 10,04%
1 jaar1j 9,34%
5 jaar5j -59,61%

Adviezen van analisten

Koersdoel

12,93 EUR

+151,13%

Consensus

Kopen

Verdeling adviezen

Onward Medical NV in het nieuws

Toon enkel gratis nieuws

8 september 2025 · ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe · Persbericht

2 september 2025 · ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 · Persbericht

18 augustus 2025 · ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System · Persbericht

6 augustus 2025 · ONWARD Medical annonce la nomination de Lucas Buchanan à son conseil d’administration · Persbericht

6 augustus 2025 · ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors · Persbericht

7 juli 2025 · ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors · Persbericht

1 juli 2025 · ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application · Persbericht

17 juni 2025 · ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025 · Persbericht

11 juni 2025 · ONWARD Medical Announces Results of its Annual General Meeting of Shareholders · Persbericht

11 juni 2025 · ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe